InMode Ltd. – NASDAQ:INMD

Add to watchlist

$14.3

-2.71

-15.98%

Market closed

Open in about 13 hours

-4.76%

month

-4.76%

quarter

-24.36%

year

Market Cap	1.44B
Enterprise value	2.79B

P/E	18.28
EV/Sales	6.15
EV/EBITDA	13.59
Price/Sales	6.35
Price/Book	5.20
PEG ratio	-7.92
EPS	2.17

Revenue	466.25M
EBITDA	173.35M
Income	181.11M
Revenue Q/Q	-24.31%
Revenue Y/Y	-1.72%

Profit margin	35.56%
Oper. margin	43.55%
Gross margin	83.82%
EBIT margin	43.55%
EBITDA margin	37.18%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

InMode Ltd. Stock Forecast

M Q Y

Last Year

$26

Potential upside: 81.81%

Analysts Price target
Financials & Ratios estimates

InMode Ltd. (NASDAQ:INMD): Profit margin
Jun 2023	136.08M	55.72M	40.95%
Sep 2023	123.11M	46.52M	37.79%
Dec 2023	126.78M	55.16M	43.51%
Mar 2024	80.28M	23.69M	29.52%

InMode Ltd. (NASDAQ:INMD): Debt to assets
Jun 2023	734084000	67.92M	9.25%
Sep 2023	793530000	70.03M	8.83%
Dec 2023	863286000	75.91M	8.79%
Mar 2024	891735000	76.3M	8.56%

InMode Ltd. (NASDAQ:INMD): Cash Flow
Jun 2023	53M	13.00M	827K
Sep 2023	41.44M	-69.82M	2.72M
Dec 2023	61.26M	-51.69M	275K
Mar 2024	24.11M	-47.39M	234K

InMode Ltd. alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

InMode Ltd. Social Media Accounts

instagram.com/inmodeaesthetics

+0.41%

month

InMode Ltd. (NASDAQ:INMD): Followers count
May 2025	104989
Jul 2025	105952
Aug 2025	106385

Google Trends

InMode

InMode Ltd. (NASDAQ:INMD): Google Trends - InMode
21 May 2023	39
28 May 2023	39
4 Jun 2023	33
11 Jun 2023	29
18 Jun 2023	47
25 Jun 2023	28
2 Jul 2023	41
9 Jul 2023	42
16 Jul 2023	38
23 Jul 2023	36
30 Jul 2023	47
6 Aug 2023	31
13 Aug 2023	29
20 Aug 2023	32
27 Aug 2023	37
3 Sep 2023	35
10 Sep 2023	27
17 Sep 2023	29
24 Sep 2023	29
1 Oct 2023	25

Non invasive Treatment

InMode Ltd. (NASDAQ:INMD): Google Trends - Non invasive Treatment
13 Aug 2023	62
20 Aug 2023	53
27 Aug 2023	51
3 Sep 2023	60
10 Sep 2023	55
17 Sep 2023	44
24 Sep 2023	45
1 Oct 2023	57
8 Oct 2023	37
15 Oct 2023	40
22 Oct 2023	34
29 Oct 2023	45
5 Nov 2023	44
12 Nov 2023	36
19 Nov 2023	49
26 Nov 2023	60
3 Dec 2023	52
10 Dec 2023	49
17 Dec 2023	56
24 Dec 2023	49

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

InMode Ltd.
Job Openings

InMode Ltd. (NASDAQ:INMD): Job openings
Aug 2023	10
Sep 2023	13
Oct 2023	8
Nov 2023	2
Dec 2023	4
Jan 2024	1
Feb 2024	0
Apr 2024	1
May 2024	2
Jun 2024	5
Jul 2024	8
Dec 2024	13
Jan 2025	13
Feb 2025	15
May 2025	8
Jul 2025	0
Aug 2025	0

InMode Ltd. (NASDAQ:INMD): Employee count
Aug 2023	480
Sep 2023	480
Oct 2023	480
Nov 2023	480
Dec 2023	480
Jan 2024	480
Feb 2024	480
Mar 2024	581
Apr 2024	581
May 2024	581
Jun 2024	581
Jul 2024	581

InMode Ltd.
Hedge Funds Holdings Q2 2022

53.63% -2.66%

of INMD is owned by hedge funds

250 -66

hedge funds hold INMD stock

46.13M -2.28M

shares is hold by hedge funds

INMD hedge funds holdings changes

Status	Patent	Filling date	Issue date
Application	Application DEVICE FOR COLLAGENOUS TISSUE TREATMENT Filling date: 4 Nov 2021 Issue date: 24 Feb 2022	4 Nov 2021	24 Feb 2022
Application	Application NASAL TISSUE TREATMENT METHOD AND RELATED DEVICE Filling date: 18 Sep 2020 Issue date: 27 Jan 2022	18 Sep 2020	27 Jan 2022
Application	Application METHOD FOR ENHANCED ELECTRO-MUSCLE STIMULATION Filling date: 15 Mar 2020 Issue date: 16 Sep 2021	15 Mar 2020	16 Sep 2021
Application	Application RF DEVICE FOR SKIN AND FAT TREATMENT Filling date: 24 May 2021 Issue date: 9 Sep 2021	24 May 2021	9 Sep 2021
Application	Application FRACTIONAL TREATMENT OF URINARY INCONTINENCE Filling date: 3 Dec 2020 Issue date: 10 Jun 2021	3 Dec 2020	10 Jun 2021
Application	Application RF FRACTIONAL DEVICE FOR TREATMENT AT DIFFERENT TISSUE DEPTHS Filling date: 8 Feb 2021 Issue date: 3 Jun 2021	8 Feb 2021	3 Jun 2021
Application	Application RF FRACTIONAL DEVICE FOR TREATMENT AT DIFFERENT TISSUE DEPTHS Filling date: 8 Feb 2021 Issue date: 3 Jun 2021	8 Feb 2021	3 Jun 2021
Application	Application RF FRACTIONAL DEVICE FOR TREATMENT AT DIFFERENT TISSUE DEPTHS Filling date: 27 Aug 2020 Issue date: 17 Dec 2020	27 Aug 2020	17 Dec 2020
Application	Application RF DEVICE FOR TISSUE TREATMENT Filling date: 6 Mar 2020 Issue date: 10 Sep 2020	6 Mar 2020	10 Sep 2020
Application	Application DEVICE FOR COLLAGENOUS TISSUE TREATMENT Filling date: 16 May 2018 Issue date: 21 Nov 2019	16 May 2018	21 Nov 2019

InMode Ltd.
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 2 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 13 Feb 2024	Q4 2023 Earnings Call Transcript
Q3 2023 2 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 27 Jul 2023	Q2 2023 Earnings Call Transcript

INMD earnings call transcripts

InMode Ltd.
Executives

Insider	Age	Compensation
Mr. Shakil Lakhani (1983) Pres of North America	42	$2,050,000
Dr. Spero Theodorou M.D. (1972) Chief Medical Officer	53	$1,620,000
Mr. Yair Malca (1978) Chief Financial Officer	47	$429,000
Dr. Michael Kreindel (1968) Chief Technology Officer & Director	57	$217,000
Mr. Moshe Mizrahy (1953) Chairman & Chief Executive Officer	72	$216,000

InMode Ltd.
Latest News

Thursday, 12 December 2024
01:17	InMode: Product Origination And Undervaluation Make The Stock A Buy	seekingalpha.com
Wednesday, 6 November 2024
08:30	InMode to Present at Upcoming Investor Conferences	prnewswire.com
Tuesday, 5 November 2024
09:43	InMode: $25/Share Is Closer Than You Think	seekingalpha.com
Thursday, 31 October 2024
12:16	InMode: A Deep Dive After Q3 Earnings	seekingalpha.com
Wednesday, 30 October 2024
11:33	InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript	seekingalpha.com
09:16	InMode (INMD) Q3 Earnings and Revenues Beat Estimates	zacks.com
07:00	InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)	prnewswire.com
Monday, 28 October 2024
16:15	Pomerantz Law Firm Announces Filing Deadline in Class Action Against InMode Ltd. and Certain Officers – INMD	accesswire.com
Thursday, 24 October 2024
07:03	InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories	prnewswire.com
Wednesday, 23 October 2024
11:07	Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline	zacks.com
Monday, 14 October 2024
10:50	Is InMode (INMD) a Great Value Stock Right Now?	zacks.com
Thursday, 10 October 2024
07:00	InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024	prnewswire.com
Friday, 4 October 2024
08:00	Stock Picks From Seeking Alpha's September 2024 New Analysts	seekingalpha.com
Tuesday, 1 October 2024
07:00	InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy	prnewswire.com
Thursday, 26 September 2024
10:46	Should Value Investors Buy InMode (INMD) Stock?	zacks.com
Thursday, 19 September 2024
07:14	InMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)	seekingalpha.com
Tuesday, 10 September 2024
10:46	Are Investors Undervaluing InMode (INMD) Right Now?	zacks.com
07:00	InMode Announces Share Repurchase Program of Up to 7.68 Million Shares	prnewswire.com
Friday, 6 September 2024
04:38	InMode Stock: An Inverse Bubble Caused By Short-Term Trouble	seekingalpha.com
Wednesday, 4 September 2024
08:30	InMode to Present at 2024 Baird Global Healthcare Conference	prnewswire.com
Tuesday, 6 August 2024
08:30	InMode to Present at Upcoming Investor Conferences	prnewswire.com
Thursday, 1 August 2024
11:19	InMode Ltd. (INMD) Q2 2024 Earnings Call Transcript	seekingalpha.com
09:15	InMode (INMD) Q2 Earnings and Revenues Top Estimates	zacks.com
07:00	InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M	prnewswire.com
Wednesday, 31 July 2024
08:03	InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform	prnewswire.com
Thursday, 25 July 2024
11:08	Analysts Estimate InMode (INMD) to Report a Decline in Earnings: What to Look Out for	zacks.com
08:15	DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer	prnewswire.com
Wednesday, 17 July 2024
08:03	Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling	prnewswire.com
Thursday, 11 July 2024
08:30	InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024	prnewswire.com
Monday, 1 July 2024
06:00	3 MedTech Stocks to Buy for Healthy Gains	investorplace.com

Ideas & Opinions

Seeking Alpha 12 Jul 2025

InMode: Margin Pressure, But Optionality Makes It Worth A Look
Seeking Alpha 28 Jan 2025

InMode: A Clear Bargain With Unique Risks
Seeking Alpha 10 Jan 2025

InMode: Clearly, I Was Too Optimistic (Rating Downgrade)
Seeking Alpha 12 Dec 2024

InMode: Product Origination And Undervaluation Make The Stock A Buy
Seeking Alpha 13 Jun 2024

InMode: Reversing Previous Shareholder Dilution With Buybacks
Seeking Alpha 4 Feb 2024

InMode: Take The Plunge Before It Goes Into Beast Mode
Seeking Alpha 21 Jan 2024

InMode: Good Margin Of Safety At Current Levels
Seeking Alpha 3 Jan 2024

InMode: Despite Attractive Valuation, I Believe It's Premature To Dive In - Here's Why
Seeking Alpha 2 Jan 2024

InMode Is Inherently Undervalued - Bullish Support Observed
Seeking Alpha 29 Nov 2023

InMode: Buying Opportunity At Oversold Market Levels

Frequently Asked Questions (FAQ)

What's the price of InMode Ltd. stock today?

One share of InMode Ltd. stock can currently be purchased for approximately $14.3.
When is InMode Ltd.'s next earnings date?

Unfortunately, InMode Ltd.'s (INMD) next earnings date is currently unknown.
Does InMode Ltd. pay dividends?

No, InMode Ltd. does not pay dividends.
How much money does InMode Ltd. make?

InMode Ltd. has a market capitalization of 1.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8.32% to 492.05M US dollars.
What is InMode Ltd.'s stock symbol?

InMode Ltd. is traded on the NASDAQ under the ticker symbol "INMD".
What is InMode Ltd.'s primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of InMode Ltd.?

Shares of InMode Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are InMode Ltd.'s key executives?
InMode Ltd.'s management team includes the following people:
- Mr. Shakil Lakhani Pres of North America(age: 42, pay: $2,050,000)
- Dr. Spero Theodorou M.D. Chief Medical Officer(age: 53, pay: $1,620,000)
- Mr. Yair Malca Chief Financial Officer(age: 47, pay: $429,000)
- Dr. Michael Kreindel Chief Technology Officer & Director(age: 57, pay: $217,000)
- Mr. Moshe Mizrahy Chairman & Chief Executive Officer(age: 72, pay: $216,000)
How many employees does InMode Ltd. have?

As Jul 2024, InMode Ltd. employs 581 workers.
When InMode Ltd. went public?

InMode Ltd. is publicly traded company for more then 6 years since IPO on 8 Aug 2019.
What is InMode Ltd.'s official website?

The official website for InMode Ltd. is inmodemd.com.
How can i contact InMode Ltd.?

InMode Ltd. can be reached via phone at +972 4 909 6313.
What is InMode Ltd. stock forecast & price target?

Based on 2 Wall Street analysts` predicted price targets for InMode Ltd. in the last 12 months, the avarage price target is $26. The average price target represents a 81.81% change from the last price of $14.3.

InMode Ltd.

inmodemd.com

Exchange:

NASDAQ

Full time employees:

581

Industry:

Medical - Devices

Sector:

Healthcare

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

+972 4 909 6313

Tavor Building
Yokne'am, 2069206

CIK: 0001742692
ISIN: IL0011595993
CUSIP: M5425M103